#EAU20 Virtual - Game changing session 2
EAU
7/18/20, 11:30 AM
Europe/Madrid GMT+2
Description
Game changing session 2
Game changing session
Sat 18 July
08:30 - 09:05
Location:Virtual room 1Chairs: J. Palou, Barcelona (ES)
K.A.O. Tikkinen, Helsinki (FI)
08:30 - 08:45
Recurrence risk in patients with High Grade Non-Muscle Invasive Bladder Carcinoma in the Randomised Phase III Clinical Trial ‘NIMBUS’ stratified for EORTC and CUETO risk categories. A contemporary trend to less recurrences?
08:30 - 08:38
Presenter
M-O. Grimm, Jena (DE)
08:38 - 08:45
Discussant
P. Black, Vancouver (CA)
08:45 - 09:00
Results from the phase III study of nadofaregene firadenovec: Safety and efficacy in patients (pts) with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
08:45 - 08:53
Presenter
N. Shore, Myrtle Beach (US)
08:53 - 09:00
Discussant
J.A. Witjes, Nijmegen (NL)
09:00 - 09:05
Discussion, questions and answers
J. Palou, Barcelona (ES)
K.A.O. Tikkinen, Helsinki (FI)
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
J. Palou, K.A.O. Tikkinen
Recurrence risk in patients with High Grade Non-Muscle Invasive Bladder Carcinoma in the Randomised Phase III Clinical Trial ‘NIMBUS’ stratified for EORTC and CUETO risk categories. A contemporary trend to less recurrences?
Inglês
Speakers
M-O. Grimm, P. Black, N. Shore, J.A. Witjes
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.